Bioamp Diagnostics Inc.
San Carlos, CA
- UEI
- DRVXMUC1N4X1
- CAGE
- 7VRB0
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 930 Brittan Ave, San Carlos, CA 94070, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Bioamp Diagnostics Inc., operating as Bioamp Diagnostics, is a woman-owned small business registered to receive federal awards since June 2017. The company specializes in developing innovative diagnostic solutions for infectious diseases, particularly focusing on antibiotic resistance detection. Bioamp Diagnostics is recognized as a minority-owned, economically disadvantaged women-owned, and Native American-owned business. Their expertise lies in creating rapid, point-of-care diagnostic tests that aim to improve patient care and antibiotic stewardship in clinical settings.
Through federal grant awards, Bioamp Diagnostics has been engaged in several significant projects addressing critical healthcare challenges. The company received a $243,806 project grant from the National Institute of Allergy and Infectious Diseases to develop a biochemical assay for detecting and classifying carbapenemase enzymes in antibiotic-resistant bacteria. This project, utilizing Bioamp's DETECT technology, aims to integrate carbapenemase detection into standard automated susceptibility testing systems, potentially revolutionizing the treatment of carbapenem-resistant infections. Additionally, Bioamp Diagnostics has been awarded funding from the National Science Foundation for the development of a rapid urine dipstick test to guide antibiotic therapy for complicated urinary tract infections. This SBIR Phase II project focuses on creating a diagnostic tool that can detect ceftriaxone-resistant uropathogens in less than 5 minutes, addressing the urgent need for faster diagnosis of drug-resistant UTIs. These projects demonstrate Bioamp Diagnostics' commitment to developing cutting-edge diagnostic technologies that can significantly impact patient care and antibiotic stewardship in healthcare settings.
Quick answers
Is Bioamp Diagnostics Inc. registered in SAM.gov?
Yes. Bioamp Diagnostics Inc.'s SAM.gov registration is active through February 20, 2027.
What is Bioamp Diagnostics Inc.'s most recent federal award?
Bioamp Diagnostics Inc.'s most recent federal grant award is Evolving the standard of care for carbapenem resistant infections, through the development of a phenotypic assay… (R43AI181482), from National Institute of Allergy and Infectious Diseases (NIH), on April 2, 2024.
On GovTribe
See Bioamp Diagnostics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors